The global Viibryd (Vilazodone) market size was valued at US$ 345 million in 2024 and is projected to reach US$ 456 million by 2030, at a CAGR of 4.7% during the forecast period 2024-2030.
United States Viibryd (Vilazodone) market size was valued at US$ 93 million in 2024 and is projected to reach US$ 119 million by 2030, at a CAGR of 4.2% during the forecast period 2024-2030.
An antidepressant medication used to treat major depressive disorder.
Report Overview
This report provides a deep insight into the global Viibryd (Vilazodone) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Viibryd (Vilazodone) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Viibryd (Vilazodone) market in any manner.
Global Viibryd (Vilazodone) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Allergan plc (AbbVie Inc.)
- Actavis Generics (Teva)
- Clinical Data, Inc.
Market Segmentation (by Type)
Market Segmentation (by Application)
- Major Depression
- Anxiety
- Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Viibryd (Vilazodone) Market
Overview of the regional outlook of the Viibryd (Vilazodone) Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the
major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Viibryd (Vilazodone)
1.2 Key Market Segments
1.2.1 Viibryd (Vilazodone) Segment by Type
1.2.2 Viibryd (Vilazodone) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Viibryd (Vilazodone) Market Overview
2.1 Global Market Overview
2.1.1 Global Viibryd (Vilazodone) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Viibryd (Vilazodone) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Viibryd (Vilazodone) Market Competitive Landscape
3.1 Global Viibryd (Vilazodone) Sales by Manufacturers (2019-2024)
3.2 Global Viibryd (Vilazodone) Revenue Market Share by Manufacturers (2019-2024)
3.3 Viibryd (Vilazodone) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Viibryd (Vilazodone) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Viibryd (Vilazodone) Sales Sites, Area Served, Product Type
3.6 Viibryd (Vilazodone) Market Competitive Situation and Trends
3.6.1 Viibryd (Vilazodone) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Viibryd (Vilazodone) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Viibryd (Vilazodone) Industry Chain Analysis
4.1 Viibryd (Vilazodone) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Viibryd (Vilazodone) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Viibryd (Vilazodone) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Viibryd (Vilazodone) Sales Market Share by Type (2019-2024)
6.3 Global Viibryd (Vilazodone) Market Size Market Share by Type (2019-2024)
6.4 Global Viibryd (Vilazodone) Price by Type (2019-2024)
7 Viibryd (Vilazodone) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Viibryd (Vilazodone) Market Sales by Application (2019-2024)
7.3 Global Viibryd (Vilazodone) Market Size (M USD) by Application (2019-2024)
7.4 Global Viibryd (Vilazodone) Sales Growth Rate by Application (2019-2024)
8 Viibryd (Vilazodone) Market Segmentation by Region
8.1 Global Viibryd (Vilazodone) Sales by Region
8.1.1 Global Viibryd (Vilazodone) Sales by Region
8.1.2 Global Viibryd (Vilazodone) Sales Market Share by Region
8.2 North America
8.2.1 North America Viibryd (Vilazodone) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Viibryd (Vilazodone) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Viibryd (Vilazodone) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Viibryd (Vilazodone) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Viibryd (Vilazodone) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Allergan plc (AbbVie Inc.)
9.1.1 Allergan plc (AbbVie Inc.) Viibryd (Vilazodone) Basic Information
9.1.2 Allergan plc (AbbVie Inc.) Viibryd (Vilazodone) Product Overview
9.1.3 Allergan plc (AbbVie Inc.) Viibryd (Vilazodone) Product Market Performance
9.1.4 Allergan plc (AbbVie Inc.) Business Overview
9.1.5 Allergan plc (AbbVie Inc.) Viibryd (Vilazodone) SWOT Analysis
9.1.6 Allergan plc (AbbVie Inc.) Recent Developments
9.2 Actavis Generics (Teva)
9.2.1 Actavis Generics (Teva) Viibryd (Vilazodone) Basic Information
9.2.2 Actavis Generics (Teva) Viibryd (Vilazodone) Product Overview
9.2.3 Actavis Generics (Teva) Viibryd (Vilazodone) Product Market Performance
9.2.4 Actavis Generics (Teva) Business Overview
9.2.5 Actavis Generics (Teva) Viibryd (Vilazodone) SWOT Analysis
9.2.6 Actavis Generics (Teva) Recent Developments
9.3 Clinical Data, Inc.
9.3.1 Clinical Data, Inc. Viibryd (Vilazodone) Basic Information
9.3.2 Clinical Data, Inc. Viibryd (Vilazodone) Product Overview
9.3.3 Clinical Data, Inc. Viibryd (Vilazodone) Product Market Performance
9.3.4 Clinical Data, Inc. Viibryd (Vilazodone) SWOT Analysis
9.3.5 Clinical Data, Inc. Business Overview
9.3.6 Clinical Data, Inc. Recent Developments
10 Viibryd (Vilazodone) Market Forecast by Region
10.1 Global Viibryd (Vilazodone) Market Size Forecast
10.2 Global Viibryd (Vilazodone) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Viibryd (Vilazodone) Market Size Forecast by Country
10.2.3 Asia Pacific Viibryd (Vilazodone) Market Size Forecast by Region
10.2.4 South America Viibryd (Vilazodone) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Viibryd (Vilazodone) by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Viibryd (Vilazodone) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Viibryd (Vilazodone) by Type (2025-2030)
11.1.2 Global Viibryd (Vilazodone) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Viibryd (Vilazodone) by Type (2025-2030)
11.2 Global Viibryd (Vilazodone) Market Forecast by Application (2025-2030)
11.2.1 Global Viibryd (Vilazodone) Sales (Kilotons) Forecast by Application
11.2.2 Global Viibryd (Vilazodone) Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Viibryd (Vilazodone) Market Size Comparison by Region (M USD)
Table 5. Global Viibryd (Vilazodone) Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Viibryd (Vilazodone) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Viibryd (Vilazodone) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Viibryd (Vilazodone) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viibryd (Vilazodone) as of 2022)
Table 10. Global Market Viibryd (Vilazodone) Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Viibryd (Vilazodone) Sales Sites and Area Served
Table 12. Manufacturers Viibryd (Vilazodone) Product Type
Table 13. Global Viibryd (Vilazodone) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Viibryd (Vilazodone)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Viibryd (Vilazodone) Market Challenges
Table 22. Global Viibryd (Vilazodone) Sales by Type (Kilotons)
Table 23. Global Viibryd (Vilazodone) Market Size by Type (M USD)
Table 24. Global Viibryd (Vilazodone) Sales (Kilotons) by Type (2019-2024)
Table 25. Global Viibryd (Vilazodone) Sales Market Share by Type (2019-2024)
Table 26. Global Viibryd (Vilazodone) Market Size (M USD) by Type (2019-2024)
Table 27. Global Viibryd (Vilazodone) Market Size Share by Type (2019-2024)
Table 28. Global Viibryd (Vilazodone) Price (USD/Ton) by Type (2019-2024)
Table 29. Global Viibryd (Vilazodone) Sales (Kilotons) by Application
Table 30. Global Viibryd (Vilazodone) Market Size by Application
Table 31. Global Viibryd (Vilazodone) Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Viibryd (Vilazodone) Sales Market Share by Application (2019-2024)
Table 33. Global Viibryd (Vilazodone) Sales by Application (2019-2024) & (M USD)
Table 34. Global Viibryd (Vilazodone) Market Share by Application (2019-2024)
Table 35. Global Viibryd (Vilazodone) Sales Growth Rate by Application (2019-2024)
Table 36. Global Viibryd (Vilazodone) Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Viibryd (Vilazodone) Sales Market Share by Region (2019-2024)
Table 38. North America Viibryd (Vilazodone) Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Viibryd (Vilazodone) Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Viibryd (Vilazodone) Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Viibryd (Vilazodone) Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Viibryd (Vilazodone) Sales by Region (2019-2024) & (Kilotons)
Table 43. Allergan plc (AbbVie Inc.) Viibryd (Vilazodone) Basic Information
Table 44. Allergan plc (AbbVie Inc.) Viibryd (Vilazodone) Product Overview
Table 45. Allergan plc (AbbVie Inc.) Viibryd (Vilazodone) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Allergan plc (AbbVie Inc.) Business Overview
Table 47. Allergan plc (AbbVie Inc.) Viibryd (Vilazodone) SWOT Analysis
Table 48. Allergan plc (AbbVie Inc.) Recent Developments
Table 49. Actavis Generics (Teva) Viibryd (Vilazodone) Basic Information
Table 50. Actavis Generics (Teva) Viibryd (Vilazodone) Product Overview
Table 51. Actavis Generics (Teva) Viibryd (Vilazodone) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Actavis Generics (Teva) Business Overview
Table 53. Actavis Generics (Teva) Viibryd (Vilazodone) SWOT Analysis
Table 54. Actavis Generics (Teva) Recent Developments
Table 55. Clinical Data, Inc. Viibryd (Vilazodone) Basic Information
Table 56. Clinical Data, Inc. Viibryd (Vilazodone) Product Overview
Table 57. Clinical Data, Inc. Viibryd (Vilazodone) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Clinical Data, Inc. Viibryd (Vilazodone) SWOT Analysis
Table 59. Clinical Data, Inc. Business Overview
Table 60. Clinical Data, Inc. Recent Developments
Table 61. Global Viibryd (Vilazodone) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 62. Global Viibryd (Vilazodone) Market Size Forecast by Region (2025-2030) & (M USD)
Table 63. North America Viibryd (Vilazodone) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 64. North America Viibryd (Vilazodone) Market Size Forecast by Country (2025-2030) & (M USD)
Table 65. Europe Viibryd (Vilazodone) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 66. Europe Viibryd (Vilazodone) Market Size Forecast by Country (2025-2030) & (M USD)
Table 67. Asia Pacific Viibryd (Vilazodone) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 68. Asia Pacific Viibryd (Vilazodone) Market Size Forecast by Region (2025-2030) & (M USD)
Table 69. South America Viibryd (Vilazodone) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 70. South America Viibryd (Vilazodone) Market Size Forecast by Country (2025-2030) & (M USD)
Table 71. Middle East and Africa Viibryd (Vilazodone) Consumption Forecast by Country (2025-2030) & (Units)
Table 72. Middle East and Africa Viibryd (Vilazodone) Market Size Forecast by Country (2025-2030) & (M USD)
Table 73. Global Viibryd (Vilazodone) Sales Forecast by Type (2025-2030) & (Kilotons)
Table 74. Global Viibryd (Vilazodone) Market Size Forecast by Type (2025-2030) & (M USD)
Table 75. Global Viibryd (Vilazodone) Price Forecast by Type (2025-2030) & (USD/Ton)
Table 76. Global Viibryd (Vilazodone) Sales (Kilotons) Forecast by Application (2025-2030)
Table 77. Global Viibryd (Vilazodone) Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Viibryd (Vilazodone)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Viibryd (Vilazodone) Market Size (M USD), 2019-2030
Figure 5. Global Viibryd (Vilazodone) Market Size (M USD) (2019-2030)
Figure 6. Global Viibryd (Vilazodone) Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Viibryd (Vilazodone) Market Size by Country (M USD)
Figure 11. Viibryd (Vilazodone) Sales Share by Manufacturers in 2023
Figure 12. Global Viibryd (Vilazodone) Revenue Share by Manufacturers in 2023
Figure 13. Viibryd (Vilazodone) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Viibryd (Vilazodone) Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Viibryd (Vilazodone) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Viibryd (Vilazodone) Market Share by Type
Figure 18. Sales Market Share of Viibryd (Vilazodone) by Type (2019-2024)
Figure 19. Sales Market Share of Viibryd (Vilazodone) by Type in 2023
Figure 20. Market Size Share of Viibryd (Vilazodone) by Type (2019-2024)
Figure 21. Market Size Market Share of Viibryd (Vilazodone) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Viibryd (Vilazodone) Market Share by Application
Figure 24. Global Viibryd (Vilazodone) Sales Market Share by Application (2019-2024)
Figure 25. Global Viibryd (Vilazodone) Sales Market Share by Application in 2023
Figure 26. Global Viibryd (Vilazodone) Market Share by Application (2019-2024)
Figure 27. Global Viibryd (Vilazodone) Market Share by Application in 2023
Figure 28. Global Viibryd (Vilazodone) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Viibryd (Vilazodone) Sales Market Share by Region (2019-2024)
Figure 30. North America Viibryd (Vilazodone) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Viibryd (Vilazodone) Sales Market Share by Country in 2023
Figure 32. U.S. Viibryd (Vilazodone) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Viibryd (Vilazodone) Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Viibryd (Vilazodone) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Viibryd (Vilazodone) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Viibryd (Vilazodone) Sales Market Share by Country in 2023
Figure 37. Germany Viibryd (Vilazodone) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Viibryd (Vilazodone) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Viibryd (Vilazodone) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Viibryd (Vilazodone) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Viibryd (Vilazodone) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Viibryd (Vilazodone) Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Viibryd (Vilazodone) Sales Market Share by Region in 2023
Figure 44. China Viibryd (Vilazodone) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Viibryd (Vilazodone) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Viibryd (Vilazodone) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Viibryd (Vilazodone) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Viibryd (Vilazodone) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Viibryd (Vilazodone) Sales and Growth Rate (Kilotons)
Figure 50. South America Viibryd (Vilazodone) Sales Market Share by Country in 2023
Figure 51. Brazil Viibryd (Vilazodone) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Viibryd (Vilazodone) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Viibryd (Vilazodone) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Viibryd (Vilazodone) Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Viibryd (Vilazodone) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Viibryd (Vilazodone) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Viibryd (Vilazodone) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Viibryd (Vilazodone) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Viibryd (Vilazodone) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Viibryd (Vilazodone) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Viibryd (Vilazodone) Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Viibryd (Vilazodone) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Viibryd (Vilazodone) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Viibryd (Vilazodone) Market Share Forecast by Type (2025-2030)
Figure 65. Global Viibryd (Vilazodone) Sales Forecast by Application (2025-2030)
Figure 66. Global Viibryd (Vilazodone) Market Share Forecast by Application (2025-2030)
